Project Number 5R21AG031037-02 Agency/Funding Organization NIA Funding Year 2008 View Full Project Details for NICOTINE/CANNABINOID THERAPY FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator SHYTLE, R. DOUGLAS Principal Investigator First Name R. DOUGLAS Principal Investigator Last Name SHYTLE Awardee Organization UNIVERSITY OF SOUTH FLORIDA Awardee State Florida Contact PI Country United States Project Detail Funding Opportunity Announcement PA-03-107: NIH EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT AWARD (R21) FY Overall Cost $181,178 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [AlzPED] Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
